Marks the world’s first implementation in a large-scale semiconductor manufacturing plant, with full-scale introduction in the EDS process planned for April 2024 Santa Clara, CA and Kyoto, Japan, Dec.

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Company to illustrate impact of production process optimization with preclinical and clinical data from product candidates P-PSMA-101 and P-BCMA-101 SAN DIEGO, Sept. 16, 2020 /PRNewswire/ -- Poseida ...

Tampa, Florida, June 24, 2025 (GLOBE NEWSWIRE) -- Advantive, a mission-critical software provider for specialty manufacturing and distribution businesses, today announced the release of WinSPC 10, the ...

In recent years, significant advancements in ML have influenced several fields beyond computer science, including autonomous driving, structural color design, medicine, and face recognition. The ...

Laser-based manufacturing and materials processing technology has proven to be a well-established and cutting-edge technology ...

DETROIT, Dec. 23, 2025 /PRNewswire/ -- Lightweighting is no longer a unique advantage in the automotive industry. Although lightweight materials are widely adopted, production waste and losses remain ...

New integration and patterning schemes used in 3D memory and logic devices have created manufacturing and yield challenges. Industrial focus has shifted from the scaling of predictable unit processes ...

The way products are made can significantly affect product quality and production costs, but can also directly affect a company’s overall operational efficiency and environmental impacts in less ...

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 17, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a commercial biopharmaceutical company dedicated to manufacturing, ...